肌少症患者生存质量评估工具的研究进展
Research progress in measurement tools of the quality of life for sarcopenia patients
  
DOI:10.3969/j.issn.1006.7108.2023.03.021
中文关键词:  肌少症  生存质量  评估工具  影响因素  综述
英文关键词:sarcopenia  quality of life  measurement tools  influencing factors  research progress
基金项目:中华护理学会科研项目(ZHKY201910);贵州省卫生健康委员会科学技术基金(gzwkj2021-476)
作者单位
唐欢1 李娟2* 唐泽丽1 余欢2 陈丽华3 郝明青3 1.遵义医科大学贵州 遵义 563003 2.贵州省人民医院贵州 贵阳 550001 3.贵州中医药大学贵州 贵阳 550002 
摘要点击次数: 724
全文下载次数: 0
中文摘要:
      肌少症是以全身肌肉进行性损失增高和机体功能下降为特点的老年综合征,可增加患者失能、骨折和跌倒等风险,严重危害患者的生存质量。目前,我国对于肌少症的研究处于起步阶段,研究重心多倾向于发病机制、诊断评估及康复治疗等方面,生存质量尚未引起广泛重视。该文对肌少症患者生存质量的评估工具、影响因素及未来研究启示进行综述,旨在为肌少症患者生存质量评估工具的本土化发展,临床实践选择合适的评估工具并深入开展相关领域的研究提供依据。
英文摘要:
      Sarcopenia is the aging symptom?complex with progressive reduction and decline of skeletal muscle mass and strength, which increases the danger of disability, fracture, fall, and greatly endangers the quality of life of the patients. At present, the research on sarcopenia in China is in the early stage. Most research is heavily weighted in favour of pathogenesis, diagnosis and assessment, and rehabilitation treatment. The quality of survival has not yet been widely emphasized. This article reviews the assessment tools, factors influencing the quality of survival of the patients with sarcopenia and future research implications, with the aim of providing a basis for the development of localized tools for assessing the quality of survival of sarcopenia patients, the selection of appropriate assessment tools for medical practice, and in-depth research in related fields.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FC9DA7BF2F842A3BAE24B54F70914FE636C4E64E3D2463703406A3F7D5A296C1519658B478DD32589EDA2326A8599FC51C053FADBD8820AE3127BD7903176C0994932E2A438E24833163FDF0CC2C40D3B7BB394909AFBD79&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=BA1E75DF0B7E0EB2&aid=8BC682C8AB0DA85A7B87C3A5971ED494&vid=&iid=38B194292C032A66&sid=6D6BFCF0101BC091&eid=08076B8B3CC96095&fileno=20230321&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="BA1E75DF0B7E0EB2"; var my_aid="8BC682C8AB0DA85A7B87C3A5971ED494";